Gabriella Gobbi, MD, PhD is a psychiatrist and neuroscientist, Professor of Psychiatry, McGill University, Canada.

Dr. Gobbi leads a laboratory of basic science (Neurobiological Psychiatry Unit) and works as a Staff Psychiatrist at the McGill University Health Center.

Her research approach spans from bench to bedside, bridging the gaps between fundamental and clinical research.

Dr Gobbi’s lab is interested in understanding the pathophysiology of psychiatric diseases and in the discovery of new treatments and cures for them.

Her laboratory is studying the short- and long-term effects of cannabis use in mental health, the mechanism of action of psychedelics drugs and their potential clinical use. Her lab also discovered and patented novel selective agonists of the melatonin MT1 and MT2 receptors for pain, insomnia and anxiety.